Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.
Earn CME for listening at www.thecarlatreport.com/podcastcme
All content for The Carlat Psychiatry Podcast is the property of Pocket Psychiatry: A Carlat Podcast and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.
Earn CME for listening at www.thecarlatreport.com/podcastcme
The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.CME: Take the CME Post-Test for this Episode (https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/5523-a-new-fda-approval-brings-new-psychiatric-risks)Published On: 09/01/2025Duration: 16 minutes, 42 secondsChris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
The Carlat Psychiatry Podcast
Clear, engaging, and practical updates on clinical psychiatry. Hosted by Chris Aiken, MD, and Kellie Newsome, PMHNP.
Earn CME for listening at www.thecarlatreport.com/podcastcme
